Inspiratory Muscle Training (IMT) in Adult People With Pompe Disease (LOPD01)
Efficacy and Feasibility of Inspiratory Muscle Training (IMT) in Adult People With Pompe Disease: a Multicentre, Cross-over Randomized Control Trial (RCT)
Sponsor: Associazione Italiana Glicogenosi (AIG)
This NA trial investigates Glycogen Storage Disease Type II and Pompe Disease (Late-onset) and is currently ongoing. Associazione Italiana Glicogenosi (AIG) leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Aug 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Aug 2023 — Jul 2024 [monthly]
Recruiting NA
First recorded
Mar 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Associazione Italiana Glicogenosi (AIG)
- Associazione Riabilitatori Insufficienza Respiratoria (ArIR)
- Fondazione Don Carlo Gnocchi Onlus
- S.C. di Pneumologia Azienda Sanitaria Universitaria Integrata di Trieste
- U.O.C. AO Ospedali Riuniti Villa Sofia-Cervello, Palermo
For direct contact, visit the study record on ClinicalTrials.gov .